相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Accuracy of four fecal assays in the diagnosis of colitis
Alain M. Schoepfer et al.
DISEASES OF THE COLON & RECTUM (2007)
Assessment of endoscopic activity lndex and biological lnflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level
Marie-Arrhelle Denis et al.
INFLAMMATORY BOWEL DISEASES (2007)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
Paul Rutgeerts et al.
GUT (2007)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease
Kaija-Leena Kolho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
P Rutgeerts et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis
J Langhorst et al.
INFLAMMATORY BOWEL DISEASES (2005)
Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease
K Geboes et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Fecal lactoferrin: A new parameter to monitor infliximab therapy
S Buderus et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Review article: Crohn's disease: monitoring disease activity
R Sostegni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
CB Summerton et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
E Aadland et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease
IDR Arnott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
A review of activity indices and efficacy Endpoints for clinical trials of medical therapy in adults with Crohn's disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)
Fecal calprotectin: Validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease
SK Bunn et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2001)
分享论文
